Understanding how COVID-19 causes severe lung inflammation
Regulation of Pathologic Inflammasome Responses to SARS-CoV-2
This study is looking into how COVID-19 can lead to serious breathing problems by examining the body's inflammatory response, with the hope of finding new ways to help patients who are struggling with severe symptoms.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-11094042 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind acute respiratory distress syndrome (ARDS) caused by COVID-19, focusing on the role of inflammasomes in the excessive release of inflammatory cytokines. By analyzing patient data and conducting experiments with human airway cells, the study aims to uncover how SARS-CoV-2 infection triggers harmful inflammatory responses. The goal is to identify molecular pathways that could be targeted for therapeutic intervention to reduce severe outcomes in COVID-19 patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced severe COVID-19 symptoms, particularly those with acute respiratory distress syndrome.
Not a fit: Patients with mild or asymptomatic COVID-19 infections are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that prevent severe lung inflammation in COVID-19 patients, potentially saving lives.
How similar studies have performed: Previous research has shown that targeting inflammatory pathways can improve outcomes in severe COVID-19 cases, suggesting that this approach may be promising.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Barnett, Katherine Camille — Univ of North Carolina Chapel Hill
- Study coordinator: Barnett, Katherine Camille
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.